Ultragenyx Pharmaceutical (RARE) P/E (2014 - 2026)
Ultragenyx Pharmaceutical (RARE) P/E from Jan 31, 2014 to Jul 21, 2026. The TTM Ultragenyx Pharmaceutical (RARE) P/E is -4.56. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Ultragenyx Pharmaceutical (RARE)
| Year | P/E | Change |
|---|---|---|
| 2026 | -4.56 | +19.00% |
| 2025 | -3.83 | -42.00% |
| 2024 | -6.61 | +23.37% |
| 2023 | -5.35 | +12.15% |
| 2022 | -4.77 | -62.16% |
| 2021 | -12.62 | -72.00% |
| 2020 | -45.05 | +636.92% |
| 2019 | -6.11 | -45.20% |
| 2018 | -11.16 | +66.60% |
| 2017 | -6.70 | -44.27% |
| 2016 | -12.02 | -58.69% |
| 2015 | -29.09 | +27.75% |
| 2014 | -22.77 | N/A |
Comparison Ultragenyx Pharmaceutical (RARE) P/E with competitors
Ultragenyx Pharmaceutical (RARE) P/E is -4.56.